Scientists test drug safety in people with liver problems
NCT ID NCT06442436
Summary
This study aims to understand how a moderate liver condition affects how the body processes a single dose of the drug nemtabrutinib. It will compare 32 participants—some with stable, moderate liver impairment and some healthy—to see how much of the drug stays in their blood and check for side effects. The goal is to gather safety and dosing information for future use in people with liver issues.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC IMPAIRMENT (HI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Clinical Pharmacology of Miami ( Site 0003)
RECRUITINGMiami, Florida, 33172, United States
Contact Phone: •••-•••-••••
-
Orlando Clinical Research Center ( Site 0001)
RECRUITINGOrlando, Florida, 32809, United States
Contact Phone: •••-•••-••••
-
Texas Liver Institute ( Site 0002)
RECRUITINGSan Antonio, Texas, 78215, United States
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.